Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Updated on: February 18,2024

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Updated on:February 18,2024

Cancer in adolescent and young adult women before pregnancy does not increase risk for stillborn births, study finds

by Deborah Mann Lake,University of Texas Health Science Center at HoustonCredit: Unsplash/CC0 Public DomainAdolescent and young adult women who were diagnosed with cancer and received chemothera

Updated on: January 23,2024

Cancer in adolescent and young adult women before pregnancy does not increase risk for stillborn births, study finds

by Deborah Mann Lake,University of Texas Health Science Center at HoustonCredit: Unsplash/CC0 Public DomainAdolescent and young adult women who were diagnosed with cancer and received chemothera

Updated on:January 23,2024

Vaccination with senescent cells reduces tumor formation in mice

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainCells that have permanently stopped multiplying, so-called senescent cells, could play an important role in the fight against cancer, acco

Updated on: February 01,2024

Vaccination with senescent cells reduces tumor formation in mice

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainCells that have permanently stopped multiplying, so-called senescent cells, could play an important role in the fight against cancer, acco

Updated on:February 01,2024

Nature-inspired peptide shows anti-tumor activity

by Forschung & Bildung GmbHStructure and synthesis of kalata-type cyclotides. Pie-shaped flow chart demonstrates the solid phase peptide synthesis of kalata-type cyclotides by example of T20K. The

Updated on: January 07,2024

Nature-inspired peptide shows anti-tumor activity

by Forschung & Bildung GmbHStructure and synthesis of kalata-type cyclotides. Pie-shaped flow chart demonstrates the solid phase peptide synthesis of kalata-type cyclotides by example of T20K. The

Updated on:January 07,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on: February 18,2024

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI

Updated on:February 18,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on: February 18,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on:February 18,2024

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Updated on: April 09,2024

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Updated on:April 09,2024

Rethinking the protein inhibitor approach to cancer therapy

byStony Brook UniversityTwo-step strategy for repeatable site-specific gene circuit integration.a, Network diagram of regulatory interactions and phenotypic impacts for native and ectopic

Updated on: January 22,2024

Rethinking the protein inhibitor approach to cancer therapy

byStony Brook UniversityTwo-step strategy for repeatable site-specific gene circuit integration.a, Network diagram of regulatory interactions and phenotypic impacts for native and ectopic

Updated on:January 22,2024

Experts explain treatment options for a common cancer complication

byThe Endocrine SocietyOsteoclast formation, activity, and pharmacologic inhibition. (A) Osteoclasts develop from osteoclast precursor cells when receptor activator of nuclear factor κ B (RANK)

Updated on: January 22,2024

Experts explain treatment options for a common cancer complication

byThe Endocrine SocietyOsteoclast formation, activity, and pharmacologic inhibition. (A) Osteoclasts develop from osteoclast precursor cells when receptor activator of nuclear factor κ B (RANK)

Updated on:January 22,2024

Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

by SPIEMicroscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The

Updated on: March 20,2024

Researchers use microscopy plus deep learning to advance prostate cancer diagnosis

by SPIEMicroscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The

Updated on:March 20,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on: April 28,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on:April 28,2024

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on: May 20,2024

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on:May 20,2024